enGene Holdings Inc. (NASDAQ:ENGNW – Get Free Report)’s stock price traded up 5.6% during mid-day trading on Monday . The stock traded as high as $0.76 and last traded at $0.76. 5,032 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 16,072 shares. The stock had previously closed at $0.72.
enGene Stock Up 5.6 %
The firm has a 50 day moving average price of $0.92 and a 200-day moving average price of $1.25.
About enGene
enGene Holdings Inc, through its subsidiary enGene, Inc, operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin.
See Also
- Five stocks we like better than enGene
- How to Short Nasdaq: An Easy-to-Follow Guide
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Breakout Stocks: What They Are and How to Identify Them
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for enGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for enGene and related companies with MarketBeat.com's FREE daily email newsletter.
